FDA approves first cell-based gene therapies for sickle cell disease
For the first time, the FDA has approved two cell-based gene therapies for treating the rare but potentially fatal sickle cell disease. One is also the first approved therapy to utilize the CRISPR/Cas9 gene editing technology, signifying innovative adv… Continue reading FDA approves first cell-based gene therapies for sickle cell disease
